Kyntra Bio, Inc. KYNB
NASDAQ · United States · Health Technology
$6.31-0.19 (-2.92%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | 2.96 | -3.18 | +193.0% | -$1.50M | -171.8% | -0.7%$7.10→$7.05 |
| Q1 2026 | 2026-05-11 | -3.74 | -3.36 | -11.3% | — | — | +4.0%$6.95→$7.22 |
| Q4 2025 | 2026-03-16 | -3.51 | -3.88 | +9.5% | — | — | +5.7%$6.97→$7.37 |
| Q3 2025 | 2025-11-10 | -1.61 | -4.01 | +59.9% | — | — | -9.9%$11.03→$9.94 |
| Q4 2024 | 2025-03-17 | -2.00 | -5.00 | +60.0% | — | — | — |
| Q1 2024 | 2024-05-06 | -8.25 | -7.75 | -6.5% | — | — | — |
| Q4 2023 | 2024-02-26 | -14.25 | -10.50 | -35.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.